![](/images/general/no_picture/200_user.png)
Son T Dinh
Examiner (ID: 2758, Phone: (571)272-1868 , Office: P/2824 )
Most Active Art Unit | 2824 |
Art Unit(s) | 2502, 2818, 2511, 2824 |
Total Applications | 2989 |
Issued Applications | 2803 |
Pending Applications | 88 |
Abandoned Applications | 98 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 11075762
[patent_doc_number] => 20160272726
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-22
[patent_title] => 'PREVENTION AND TREATMENT OF COMPLEMENT-ASSOCIATED EYE CONDITIONS'
[patent_app_type] => utility
[patent_app_number] => 15/014886
[patent_app_country] => US
[patent_app_date] => 2016-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 18474
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15014886
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/014886 | PREVENTION AND TREATMENT OF COMPLEMENT-ASSOCIATED EYE CONDITIONS | Feb 2, 2016 | Abandoned |
Array
(
[id] => 11054456
[patent_doc_number] => 20160251418
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-01
[patent_title] => 'ANTI-TRANSTHYRETIN ANTIBODIES'
[patent_app_type] => utility
[patent_app_number] => 15/009662
[patent_app_country] => US
[patent_app_date] => 2016-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 38444
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15009662
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/009662 | ANTI-TRANSTHYRETIN ANTIBODIES | Jan 27, 2016 | Abandoned |
Array
(
[id] => 11060775
[patent_doc_number] => 20160257736
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-08
[patent_title] => 'ANTI-TRANSTHYRETIN ANTIBODIES'
[patent_app_type] => utility
[patent_app_number] => 15/009666
[patent_app_country] => US
[patent_app_date] => 2016-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 29814
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15009666
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/009666 | ANTI-TRANSTHYRETIN ANTIBODIES | Jan 27, 2016 | Abandoned |
Array
(
[id] => 11054455
[patent_doc_number] => 20160251417
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-01
[patent_title] => 'ANTIBODIES RECOGNIZING MEDIN'
[patent_app_type] => utility
[patent_app_number] => 15/004854
[patent_app_country] => US
[patent_app_date] => 2016-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 29023
[patent_no_of_claims] => 72
[patent_no_of_ind_claims] => 21
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15004854
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/004854 | ANTIBODIES RECOGNIZING MEDIN | Jan 21, 2016 | Abandoned |
Array
(
[id] => 11011041
[patent_doc_number] => 20160207994
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-21
[patent_title] => 'MODULATORS OF IL-12 AND/OR IL-23 FOR THE PREVENTION OR TREATMENT OF ALZHEIMER\'S DISEASE'
[patent_app_type] => utility
[patent_app_number] => 15/000063
[patent_app_country] => US
[patent_app_date] => 2016-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 7862
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15000063
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/000063 | MODULATORS OF IL-12 AND/OR IL-23 FOR THE PREVENTION OR TREATMENT OF ALZHEIMER'S DISEASE | Jan 18, 2016 | Abandoned |
Array
(
[id] => 11350232
[patent_doc_number] => 20160368973
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-22
[patent_title] => 'ANTI-COMPLEMENT FACTOR C1Q ANTIBODIES AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/989038
[patent_app_country] => US
[patent_app_date] => 2016-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 37849
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14989038
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/989038 | Anti-complement factor C1q antibodies and uses thereof | Jan 5, 2016 | Issued |
Array
(
[id] => 13037431
[patent_doc_number] => 10040835
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-08-07
[patent_title] => Vectors encoding rod-derived cone viability factor
[patent_app_type] => utility
[patent_app_number] => 14/962337
[patent_app_country] => US
[patent_app_date] => 2015-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 15
[patent_no_of_words] => 18240
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14962337
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/962337 | Vectors encoding rod-derived cone viability factor | Dec 7, 2015 | Issued |
Array
(
[id] => 11657283
[patent_doc_number] => 09670273
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-06-06
[patent_title] => 'Humanized antibodies that recognize alpha-synuclein'
[patent_app_type] => utility
[patent_app_number] => 14/937792
[patent_app_country] => US
[patent_app_date] => 2015-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 14
[patent_no_of_words] => 18289
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14937792
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/937792 | Humanized antibodies that recognize alpha-synuclein | Nov 9, 2015 | Issued |
Array
(
[id] => 15102613
[patent_doc_number] => 10472607
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-11-12
[patent_title] => Culture medium and method for inducing differentiation of pluripotent stem cells into neuroepithelial cells
[patent_app_type] => utility
[patent_app_number] => 14/932507
[patent_app_country] => US
[patent_app_date] => 2015-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 26
[patent_no_of_words] => 4716
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14932507
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/932507 | Culture medium and method for inducing differentiation of pluripotent stem cells into neuroepithelial cells | Nov 3, 2015 | Issued |
Array
(
[id] => 14007869
[patent_doc_number] => 10222386
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-03-05
[patent_title] => Biomarkers of congnitive dysfunction
[patent_app_type] => utility
[patent_app_number] => 15/511860
[patent_app_country] => US
[patent_app_date] => 2015-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 51
[patent_figures_cnt] => 95
[patent_no_of_words] => 34409
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15511860
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/511860 | Biomarkers of congnitive dysfunction | Sep 17, 2015 | Issued |
Array
(
[id] => 10492890
[patent_doc_number] => 20150377912
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-31
[patent_title] => 'Method for Determining and Treating Amyotrophic Lateral Sclerosis'
[patent_app_type] => utility
[patent_app_number] => 14/854051
[patent_app_country] => US
[patent_app_date] => 2015-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5308
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14854051
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/854051 | Method for determining and treating amyotrophic lateral sclerosis | Sep 14, 2015 | Issued |
Array
(
[id] => 16230582
[patent_doc_number] => 10738122
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-08-11
[patent_title] => Compositions and methods for treating and preventing inflammation
[patent_app_type] => utility
[patent_app_number] => 15/507407
[patent_app_country] => US
[patent_app_date] => 2015-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 72
[patent_figures_cnt] => 55
[patent_no_of_words] => 29555
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15507407
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/507407 | Compositions and methods for treating and preventing inflammation | Sep 7, 2015 | Issued |
Array
(
[id] => 11969865
[patent_doc_number] => 20170274019
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-28
[patent_title] => 'RETINAL GANGLION CELLS AND PROGENITORS THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/508533
[patent_app_country] => US
[patent_app_date] => 2015-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 31857
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15508533
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/508533 | RETINAL GANGLION CELLS AND PROGENITORS THEREOF | Sep 4, 2015 | Pending |
Array
(
[id] => 11977653
[patent_doc_number] => 20170281807
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-05
[patent_title] => 'TARGETING IMMUNOTHERAPY FOR AMYLOIDOSIS'
[patent_app_type] => utility
[patent_app_number] => 15/504512
[patent_app_country] => US
[patent_app_date] => 2015-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 22244
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15504512
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/504512 | Targeting immunotherapy for amyloidosis | Aug 23, 2015 | Issued |
Array
(
[id] => 11950666
[patent_doc_number] => 20170254818
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-07
[patent_title] => 'CNS-SPECIFIC BIOMARKERS FOR CNS DISEASES OR INJURIES'
[patent_app_type] => utility
[patent_app_number] => 15/506325
[patent_app_country] => US
[patent_app_date] => 2015-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 13323
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15506325
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/506325 | CNS-SPECIFIC BIOMARKERS FOR CNS DISEASES OR INJURIES | Aug 23, 2015 | Abandoned |
Array
(
[id] => 11995458
[patent_doc_number] => 20170299614
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-19
[patent_title] => 'Alzheimer\'s Disease'
[patent_app_type] => utility
[patent_app_number] => 15/501811
[patent_app_country] => US
[patent_app_date] => 2015-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8363
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15501811
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/501811 | Alzheimer's Disease | Aug 2, 2015 | Abandoned |
Array
(
[id] => 10663622
[patent_doc_number] => 20160009766
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-14
[patent_title] => 'BACTERIOPHAGE GENE 3 PROTEIN COMPOSITIONS AND USE AS AMYLOID BINDING AGENTS'
[patent_app_type] => utility
[patent_app_number] => 14/797724
[patent_app_country] => US
[patent_app_date] => 2015-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 52
[patent_figures_cnt] => 52
[patent_no_of_words] => 26788
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14797724
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/797724 | Bacteriophage gene 3 protein compositions and use as amyloid binding agents | Jul 12, 2015 | Issued |
Array
(
[id] => 11706264
[patent_doc_number] => 20170174763
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-22
[patent_title] => 'NOGO Receptor-Mediated Blockade of Axonal Growth'
[patent_app_type] => utility
[patent_app_number] => 14/798125
[patent_app_country] => US
[patent_app_date] => 2015-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 31144
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14798125
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/798125 | NOGO Receptor-Mediated Blockade of Axonal Growth | Jul 12, 2015 | Abandoned |
Array
(
[id] => 11625879
[patent_doc_number] => 20170136068
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-18
[patent_title] => 'COMPOSITION FOR TREATING ISCHEMIC DISEASES OR NEUROINFLAMMATORY DISEASES CONTAINING NEURAL PROGENITOR CELLS OR SECRETOME THEREOF AS ACTIVE INGREDIENT'
[patent_app_type] => utility
[patent_app_number] => 15/322003
[patent_app_country] => US
[patent_app_date] => 2015-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 11318
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15322003
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/322003 | COMPOSITION FOR TREATING ISCHEMIC DISEASES OR NEUROINFLAMMATORY DISEASES CONTAINING NEURAL PROGENITOR CELLS OR SECRETOME THEREOF AS ACTIVE INGREDIENT | Jun 25, 2015 | Abandoned |
Array
(
[id] => 10483279
[patent_doc_number] => 20150368299
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-24
[patent_title] => 'AMYLOID-BETA BINDING PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 14/745758
[patent_app_country] => US
[patent_app_date] => 2015-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 43224
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14745758
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/745758 | Amyloid-beta binding proteins | Jun 21, 2015 | Issued |